Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2000 of 6351
-
Can eye movements heal trauma after a heart attack?
Symptom relief Recruiting nowCardiac events can often result in debilitating and persistent psychological symptoms. A key question involves whether optimal treatment of cardiac-induced posttraumatic stress disorder (PTSD) reduces PTSD symptoms and thereby may offset the risk of recurrent or worsening cardiov…
Sponsor: University of Zurich • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Could a sleep aid curb opioid relapse? new study tests suvorexant
Symptom relief CompletedThis study is designed to elucidate the role of the orexin neurotransmitter system in sleep disturbance and circadian rhythms of stress that might in turn influence relapse behaviors in persons on medication-assisted treatments (MAT) who are in early recovery from opioid use diso…
Phase 2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Massive biobank aims to crack the code of rare diseases
Knowledge-focused By invitation onlyThis research study is being done to find markers and identify causes of rare and undiagnosed diseases by analyzing patient's DNA (i.e., genetic material), RNA, plasma, urine, tissues, or other samples that could be informative of symptoms. Researchers are creating a biobank (lib…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Breathing exercises may enhance physiotherapy for spine condition
Symptom relief CompletedBackground and Objective: Information regarding the effects of physiotherapy on quality of life and alterations in pulmonary function tests among patients with thoracic discopathy is notably limited in the literature. This study aims to compare the effects of the classical physi…
Sponsor: Medipol University • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat colorectal cancer
Disease control CompletedThis study will test whether the combination of cisplatin, nivolumab, and temozolomide is an effective treatment for in people with advanced and/or metastatic colorectal cancer that is mismatch repair-proficient (MMR-proficient). The researchers will also look at how safe the stu…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a quick office procedure unblock stuffy noses without surgery?
Disease control Completed: Patient Information Sheet and Informed Consent Form PATIENT INFORMATION SHEET AND INFORMED CONSENT FORM (for adult subjects and interventional studies) 1. Title of study: A Prospective, Randomized, Comparative Study between Lateralization Vs Radiofrequency Ablation for Pat…
Sponsor: Goh Liang Chye • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Zapping the vagus nerve while training the brain: a new recipe for sharper aging?
Knowledge-focused CompletedDecline in brain health and associated loss of cognitive function in healthy aging decreases quality of life.We need better tools to both enhance brain health and improve cognitive performance in healthy brain aging so that it can be delayed, reduced, or even reversed. The presen…
Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Could a diabetes drug boost radiation to fight returning prostate cancer?
Disease control OngoingThis phase I/II escalation dose study is assessing the efficacy of the recommended dose of stereotactic re-irradiation (SBRT) of relapses within the prostatectomy bed, potentiated by metformin
Phase 1/2 • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Can a smart patch outsmart hidden heart risks after stroke?
Diagnosis OngoingIt is known that atrial fibrillation after stroke significantly increases the risk of stroke or systemic embolism. Accordingly, efforts have been made to detect hidden atrial fibrillation and apply treatment using anticoagulants instead of antiplatelet agents. The conventional me…
Sponsor: Ewha Womans University Mokdong Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Can a smartphone app boost Girls' confidence in sexual communication?
Symptom relief CompletedAdolescents' sexual health has been an important issue for health care professionals, education and society. The purpose of this study was to examine the impact of a mobile application on adolescent girls' sexual communication self-efficacy and sexual health outcomes. A total of …
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
Could an implant replace daily eye drops for glaucoma?
Disease control OngoingThis is a multicenter, open-label, dose escalation (Cohort 1) to masked, randomized, parallel-groups (Cohort 2) and (Cohort 3) study to evaluate the safety and efficacy of AGN-193408 SR in participants with open-angle glaucoma or ocular hypertension
Phase 1/2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New pfizer drug takes on Hard-to-Treat cancers
Disease control Recruiting nowThis is an open-label, multi center study to evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of PF-07248144 and early signs of clinical efficacy of PF-07248144 as a single agent and in combination with other agents
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Dry eye tests may reveal a new marker for hand osteoarthritis
Diagnosis CompletedThis study investigates whether the relationship between the Ocular Surface Disease Index (OSDI) and dry eye parameters can be used as a predictive marker in patients diagnosed with hand osteoarthritis. Symptoms and signs of dry eye are assessed using the OSDI questionnaire, Schi…
Sponsor: Medipol University • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC
-
Newer scope technique may outperform standard procedure for Cancer-Related bile duct blockage
Disease control CompletedThe main objective is to compare the EUS-BD with the insertion of a LAMS vs. traditional ERCP to restore biliary patency. Although ERCP has been the primary treatment for many years, it is associated with a significant risk of procedural complications and possible stent blockage.…
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New pacing technique may shield heart from failure in block patients
Disease control CompletedThis is a multicenter, randomized controlled study. The aim of this study is to compare the impact of LBBAP on left ventricular function as compared with traditional right ventricular pacing in patients with atrioventricular block.
Sponsor: Fu Wai Hospital, Beijing, China • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a 2-Day infusion save transplanted kidneys from early damage?
Disease control Recruiting nowThe objectives of this study are to test the preliminary safety and efficacy of a two-day peri-operative course of treprostinil in reducing ischemia-reperfusion injury in adult patients receiving a deceased donor kidney transplantation. Treprostinil, a prostacyclin analog, is exp…
Phase 1/2 • Sponsor: Rhode Island Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New balloon treatment aims to keep dialysis access open longer
Disease control OngoingLong-term safety will be summarized
Sponsor: Medtronic • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New radioactive bullet targets Hard-to-Treat prostate cancer
Disease control OngoingThe purpose of this study is to determine the recommended Phase 2 dose(s) (RP2D\[s\]) of JNJ-69086420 in Part 1 (Dose Escalation), to determine safety and preliminary signs of clinical activity at the RP2D(s) in Part 2 (Dose Expansion), to determine safety of JNJ-69086420 at the …
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug cocktail aims to shrink Hard-to-Treat cancers
Disease control OngoingThis research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer agents is safe, tolerable, and has anti-cancer activity in patients with advanced solid tumors.
Phase 1/2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New drug shows promise for Sjögren's syndrome in early trial
Disease control CompletedPrimary Objective: To evaluate the therapeutic efficacy of one dose level of SAR441344 versus placebo over 12 weeks in adult patients with primary Sjögren's syndrome (pSjS), assessed by the change of the European League Against Rheumatism (EULAR) Sjögren's Syndrome Disease Activ…
Phase 2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC